Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2000 Oct;55(10):860–863. doi: 10.1136/thorax.55.10.860

Malignant vascular tumours of the pleura in "asbestos" workers and endothelial differentiation in malignant mesothelioma

R Attanoos 1, S Suvarna 1, E Rhead 1, M Stephens 1, T Locke 1, M Sheppard 1, F Pooley 1, A Gibbs 1
PMCID: PMC1745618  PMID: 10992539

Abstract

BACKGROUND—Three cases of diffuse malignant vascular tumours of the pleura are described which mimicked malignant mesothelioma clinically and pathologically (so called "pseudomesothelioma"). All had occupational histories of exposure to asbestos. The relationship of these tumours to mesothelioma and asbestos exposure is discussed.
METHODS—To examine the histogenetic relationship between mesothelioma and these three tumours an immunohistochemical analysis of vascular marker (CD31, CD34, and Von Willebrand factor) expression was undertaken in 92 cases of pleural mesothelioma, in addition to these three tumours. Electron microscopic fibre analysis of lung tissue was performed on each of the three cases to assess asbestos fibre content.
RESULTS—Diffuse pleural epithelioid haemangioendotheliomas may closely resemble malignant mesothelioma clinically and pathologically but, of the 92 pleural mesotheliomas tested, none showed expression of CD31, CD34, and Von Willebrand factor. Although all three cases had claimed exposure to asbestos, ferruginous bodies typical of asbestos were only seen by light microscopy in case 2, and only in this subject was the asbestos fibre content raised in comparison with the range seen in a non-exposed background population. The latent period in the pleural epithelioid haemangioendotheliomas ranged from 18 to 60years.
CONCLUSIONS—Endothelial differentiation does not appear to occur in mesothelioma and therefore should be clearly separated from it. No definite association between pleural epithelioid haemangioendothelioma and exposure to asbestos can be made from this small series but further investigation is warranted.



Full Text

The Full Text of this article is available as a PDF (107.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Attanoos R. L., Dallimore N. S., Gibbs A. R. Primary epithelioid haemangioendothelioma of the peritoneum: an unusual mimic of diffuse malignant mesothelioma. Histopathology. 1997 Apr;30(4):375–377. doi: 10.1046/j.1365-2559.1997.d01-611.x. [DOI] [PubMed] [Google Scholar]
  2. Churg A. Asbestos fibers and pleural plaques in a general autopsy population. Am J Pathol. 1982 Oct;109(1):88–96. [PMC free article] [PubMed] [Google Scholar]
  3. Davies D., Cotton R. Mica pneumoconiosis. Br J Ind Med. 1983 Feb;40(1):22–27. doi: 10.1136/oem.40.1.22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. De Young B. R., Frierson H. F., Jr, Ly M. N., Smith D., Swanson P. E. CD31 immunoreactivity in carcinomas and mesotheliomas. Am J Clin Pathol. 1998 Sep;110(3):374–377. doi: 10.1093/ajcp/110.3.374. [DOI] [PubMed] [Google Scholar]
  5. Donna A., Betta P. G. Mesodermomas: a new embryological approach to primary tumours of coelomic surfaces. Histopathology. 1981 Jan;5(1):31–44. doi: 10.1111/j.1365-2559.1981.tb01764.x. [DOI] [PubMed] [Google Scholar]
  6. Evans D. M., Williams W. J., Kung I. T. Angiosarcoma and hepatocellular carcinoma in vinyl chloride workers. Histopathology. 1983 May;7(3):377–388. doi: 10.1111/j.1365-2559.1983.tb02251.x. [DOI] [PubMed] [Google Scholar]
  7. Guarda L. A., Ordonez N. G., Smith J. L., Jr, Hanssen G. Immunoperoxidase localization of factor VIII in angiosarcomas. Arch Pathol Lab Med. 1982 Oct;106(10):515–516. [PubMed] [Google Scholar]
  8. Lanphear B. P., Buncher C. R. Latent period for malignant mesothelioma of occupational origin. J Occup Med. 1992 Jul;34(7):718–721. [PubMed] [Google Scholar]
  9. Lin B. T., Colby T., Gown A. M., Hammar S. P., Mertens R. B., Churg A., Battifora H. Malignant vascular tumors of the serous membranes mimicking mesothelioma. A report of 14 cases. Am J Surg Pathol. 1996 Dec;20(12):1431–1439. doi: 10.1097/00000478-199612000-00001. [DOI] [PubMed] [Google Scholar]
  10. Miettinen M., Lindenmayer A. E., Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994 Jan;7(1):82–90. [PubMed] [Google Scholar]
  11. Parums D. V., Cordell J. L., Micklem K., Heryet A. R., Gatter K. C., Mason D. Y. JC70: a new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections. J Clin Pathol. 1990 Sep;43(9):752–757. doi: 10.1136/jcp.43.9.752. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pooley F. D., Ranson D. L. Comparison of the results of asbestos fibre dust counts in lung tissue obtained by analytical electron microscopy and light microscopy. J Clin Pathol. 1986 Mar;39(3):313–317. doi: 10.1136/jcp.39.3.313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Stephens M., Gibbs A. R., Pooley F. D., Wagner J. C. Asbestos induced diffuse pleural fibrosis: pathology and mineralogy. Thorax. 1987 Aug;42(8):583–588. doi: 10.1136/thx.42.8.583. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Vallyathan V., Bergeron W. N., Robichaux P. A., Craighead J. E. Pulmonary fibrosis in an aluminum arc welder. Chest. 1982 Mar;81(3):372–374. doi: 10.1378/chest.81.3.372. [DOI] [PubMed] [Google Scholar]
  15. WAGNER J. C., SLEGGS C. A., MARCHAND P. Diffuse pleural mesothelioma and asbestos exposure in the North Western Cape Province. Br J Ind Med. 1960 Oct;17:260–271. doi: 10.1136/oem.17.4.260. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Yousem S. A., Hochholzer L. Unusual thoracic manifestations of epithelioid hemangioendothelioma. Arch Pathol Lab Med. 1987 May;111(5):459–463. [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES